Analysis of sphingosine levels from BAL. by Henning Carstens (13132801)

Histological studies of lungs stained with Cy3-coupled anti-sphingosine antibodies. by Henning Carstens (13132801)

Histological studies of lungs stained with Cy3-coupled anti-ceramide antibodies. by Henning Carstens (13132801)

Fig 7 - by Henning Carstens (13132801)

Methods of assessment of the glottic gap using a rigid endoscope. by Ikuo Mikoshiba (9312007)

Effects of FE and RUD wrist postures on the mean carpal tunnel depth within each quartile. by Drew A. Anderson (14197446)

Effects of FE and RUD wrist postures on the mean carpal tunnel width within each quartile. by Drew A. Anderson (14197446)

P-values for each factor in the full multiple regression models of volume, cross-sectional area (CSA), width, depth, Euclidean distance from the template (EDT), and phase shift rel... by Drew A. Anderson (14197446)

Division of carpal tunnel into quartiles to calculate volume distribution. by Drew A. Anderson (14197446)

Minimal dataset. by Drew A. Anderson (14197446)

Effects of FE and RUD wrist postures on carpal tunnel length. by Drew A. Anderson (14197446)

Effects of FE and RUD wrist postures on the mean cross-sectional area within each quartile. by Drew A. Anderson (14197446)

Effects of FE and RUD wrist postures on the mean shape signature distance from the template within each quartile. by Drew A. Anderson (14197446)

Effects of FE and RUD wrist postures on the mean shape signature phase shift within each quartile. by Drew A. Anderson (14197446)

Illustration of the predicted mean (n = 10) twist along the carpal tunnel in neutral and with combined FE and RUD postures. by Drew A. Anderson (14197446)

Carpal tunnel cross-sections used to calculate morphology metrics. by Drew A. Anderson (14197446)

Effects of FE and RUD wrist postures on carpal tunnel volume distribution by quartile. by Drew A. Anderson (14197446)

Fe limitation decreases transcriptional regulation over the diel cycle in the model diatom <i>Thalassiosira pseudonana</i> - Fig 2 by Johanna A. L. Goldman (7372724)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…In the non-recurrence group, visits declined from 10.4 ± 4.5 preoperatively to 7.1 ± 2.2, 3.4 ± 1.3, and 2.6 ± 1.0 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g008" target="_blank">Fig 8</a>).…”

Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A by Rodrigo Velázquez-Moctezuma (3776023)

“…Culturing J6/JFH1_ΔHVR1 (genotype 2a), for which fitness was decreased by L665W, with AR5A generated AR5A-resistant viruses with the substitutions I345V, L665S, and S680T, which we introduced into J6/JFH1 and J6/JFH1_ΔHVR1. …”